Penta

Penta is controlled by its six partners: co-founders Marek Dospiva and Jaroslav Haščák, Managing Partner Iain Child, Václav Jirků (healthcare), Marián Slivovič (banking and media), and CFO Fabrice Dumontheil. Decisions flow through the partnership structure rather than a conventional investment committee of a fund. Dospiva and Haščák oversee the full portfolio with specific emphasis on real estate and international expansion, respectively.

Penta launched an offering to qualified investors to co-invest directly into the group's portfolio alongside the founders. This is not a structured fund with a fixed life; it allows external capital to ride on the same balance sheet that built the €12.1 billion portfolio. The arrangement preserves the partnership governance while broadening capital access.

Penta takes concentrated, long-term control stakes in Central European healthcare, financial services, real estate, manufacturing, and media. Its most significant holdings include the Dr.Max pharmacy chain, Penta Hospitals, Fortuna Entertainment Group, and Penta Real Estate. The group re-invests profits to scale businesses rather than pursuing pre-determined exit horizons.

Penta historically has not disclosed a fund-of-funds or LP program. Its capital deployment is direct and proprietary, executed through its subsidiaries. The 2024 opening to external investors reversed the flow — making Penta a recipient of external co-investment rather than a provider.

The group’s capital was generated organically by founders Marek Dospiva and Jaroslav Haščák beginning in 1994. Penta has not publicly disclosed an external institutional backer or family wealth source. The firm's net profit — €714 million in 2025 — suggests substantial internal capital generation driving continued reinvestment.

Penta operates as a parent company with active operational control. It places its own partners and executives on the supervisory boards or management teams of its holdings. For example, Iain Child directs the Fortuna investment, and Václav Jirků oversees the healthcare portfolio including Dr.Max, Penta Hospitals, and the Dôvera insurance operation.

The group states it supports charitable and nonprofit projects, particularly through its corporate social responsibility efforts embedded across its businesses. It has not publicly disclosed a separate philanthropic foundation or distinct family-office entity. Responsibility work appears to flow through the operating companies themselves.